标题
Druggable host gene dependencies in primary effusion lymphoma
作者
关键词
-
出版物
Current Opinion in Virology
Volume 56, Issue -, Pages 101270
出版商
Elsevier BV
发表日期
2022-09-29
DOI
10.1016/j.coviro.2022.101270
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma
- (2022) Hilmar Quentmeier et al. Scientific Reports
- CDK4/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules
- (2022) Yiquan Wu et al. Journal of Translational Medicine
- Current Perspectives in Human T-Cell Leukemia Virus Type 1 Infection and Its Associated Diseases
- (2022) Michi Miura et al. Frontiers in Medicine
- Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2
- (2021) Prabha Shrestha et al. PLoS Pathogens
- Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen
- (2021) Zhongying Mo et al. Blood Advances
- KSHV/HHV8-mediated hematologic diseases
- (2021) Ethel Cesarman et al. BLOOD
- Cancers associated with human gammaherpesviruses
- (2021) Kwun Wah Wen et al. FEBS Journal
- Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in Adult T-cell leukemia/lymphoma
- (2021) Takashi Ishio et al. BLOOD
- Specific Inhibition of Viral MicroRNAs by Carbon Dots-Mediated Delivery of Locked Nucleic Acids for Therapy of Virus-Induced Cancer
- (2020) Enguo Ju et al. ACS Nano
- p53 programmes plough on
- (2020) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functionalMYCsuperenhancers and enhancer RNAs
- (2020) Angela Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
- (2020) Mark Manzano et al. mBio
- Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
- (2020) Chong Wang et al. Nature Communications
- In vivo models of oncoproteins encoded by Kaposi's sarcoma-associated herpesvirus
- (2019) Ariana G Bravo Cruz et al. JOURNAL OF VIROLOGY
- Viral, immunologic, and clinical features of primary effusion lymphoma
- (2019) Kathryn Lurain et al. BLOOD
- CRISPR-Cas9 Screening of Kaposi’s Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells
- (2019) Marion Gruffaz et al. mBio
- How Kaposi’s sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis
- (2019) Aurélia Faure et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Global Landscape of EBV-Associated Tumors
- (2019) Claire Shannon-Lowe et al. Frontiers in Oncology
- Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets
- (2019) Joshua M. Dempster et al. Nature Communications
- Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma
- (2018) Yi Jin et al. BLOOD
- CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma
- (2018) Ajinkya Patil et al. BLOOD
- The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
- (2018) Nikolai Schleussner et al. LEUKEMIA
- Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma
- (2018) Masao Nakagawa et al. CANCER CELL
- Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
- (2018) Mark Manzano et al. Nature Communications
- Epstein–Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus
- (2018) Rachele Bigi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
- (2018) Kendall R. Sanson et al. Nature Communications
- Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity
- (2018) Florian Full et al. Nature Microbiology
- Identification of a nucleoside analog active against adenosine kinase–expressing plasma cell malignancies
- (2017) Utthara Nayar et al. JOURNAL OF CLINICAL INVESTIGATION
- Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis
- (2016) Xiaoyan Liu et al. JOURNAL OF VIROLOGY
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- Epstein-Barr Virus Oncoprotein Super-enhancers Control B Cell Growth
- (2015) Hufeng Zhou et al. Cell Host & Microbe
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
- (2015) R Gopalakrishnan et al. ONCOGENE
- Identification and characterization of essential genes in the human genome
- (2015) T. Wang et al. SCIENCE
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity
- (2014) Matthew A. Care et al. NUCLEIC ACIDS RESEARCH
- Epstein–Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes
- (2014) Stefanie C. S. Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
- (2013) B Tolani et al. ONCOGENE
- Epstein-Barr Virus Nuclear Antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A
- (2013) S. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
- (2012) Yibin Yang et al. CANCER CELL
- A microRNA Encoded by Kaposi Sarcoma-Associated Herpesvirus Promotes B-Cell Expansion In Vivo
- (2012) Christine Dahlke et al. PLoS One
- Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines
- (2011) D. Roy et al. BLOOD
- A Kaposi's Sarcoma-Associated Herpesvirus-Encoded Ortholog of MicroRNA miR-155 Induces Human Splenic B-Cell Expansion in NOD/LtSz-scid IL2R null Mice
- (2011) I. W. Boss et al. JOURNAL OF VIROLOGY
- Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration
- (2010) Shi-Lu Luan et al. JOURNAL OF PATHOLOGY
- Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/ -catenin genes in human herpesvirus 8-associated primary effusion lymphoma
- (2009) E. Boulanger et al. HAEMATOLOGICA
- IRF4 addiction in multiple myeloma
- (2008) Arthur L. Shaffer et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started